Stock2740 wrote: "My understanding is that Resverlogix sought phase 3 trial in europe as they could not get a phase 3 qualification from FDA...."

My memory of the trial design was that it was always going to be inclusive of Europe and potentially other international participating countries, but that they were striving for concurrent FDA approval/US study sites. Since we haven't heard any concrete updates from RVX management regarding the status of their talks with FDA on BETonMACE, we cannot say one way or another whether US sites will be approved by the FDA for BETonMACE. First dosing only started 3 months ago. Patient recruitment and first dosing will continue for approximately another 9 months according to past timelines conveyed to us by RVX management. So plenty of time for more study sites, incuding US, to be added.

BearDownAZ